Neuroinflammation in Multiple System Atrophy: Response to and Cause of α-Synuclein Aggregation

Frontiers in Cellular Neuroscience
Bruno Di Marco VieiraDean L Pountney

Abstract

Multiple system atrophy (MSA) is a progressive neurodegenerative disease presenting with combinations of autonomic dysfunction, parkinsonism, cerebellar ataxia and/or pyramidal signs. Oligodendroglial cytoplasmic inclusions (GCIs) rich in α-synuclein (α-syn) constitute the disease hallmark, accompanied by neuronal loss and activation of glial cells which indicate neuroinflammation. Recent studies demonstrate that α-syn may be released from degenerating neurons to mediate formation of abnormal inclusion bodies and to induce neuroinflammation which, interestingly, might also favor the formation of intracellular α-syn aggregates as a consequence of cytokine release and the shift to a pro-inflammatory environment. Here, we critically review the relationships between α-syn and astrocytic and microglial activation in MSA to explore the potential of therapeutics which target neuroinflammation.

References

Jul 17, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·A SchragN P Quinn
Dec 23, 1998·Journal of Neuropathology and Experimental Neurology·P L Lantos
Aug 15, 2001·Biochemistry·V Narayanan, S Scarlata
Apr 19, 2002·Brain : a Journal of Neurology·Hirohisa WatanabeGen Sobue
Jan 30, 2004·Journal of Neuropathology and Experimental Neurology·Keisuke IshizawaTakanori Hirose
Feb 3, 2004·Annals of Neurology·Juan J ZarranzJusto G de Yebenes
Aug 28, 2004·Molecular Biology of the Cell·Roberta KiffinAna Maria Cuervo
Mar 26, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Wei ZhangJing Zhang
May 17, 2005·Nature Neuroscience·Dimitrios DavalosWen-Biao Gan
Jun 7, 2005·Journal of Neuroinflammation·Emilie CroisierManuel B Graeber
Nov 15, 2005·Journal of Neural Transmission·D W MillerA B Young
Jun 17, 2006·Current Opinion in Pharmacology·Mauro KramperaFrancesco Annunziato
Dec 21, 2006·Nature Reviews. Neuroscience·Michelle L BlockJau-Shyong Hong
Sep 14, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Nadia StefanovaGregor K Wenning
Oct 16, 2007·Journal of the Neurological Sciences·Jacques De KeyserMarcus W Koch
Nov 10, 2007·Neuropathology and Applied Neurobiology·J Q TrojanowskiUNKNOWN Neuropathology Working Group on MSA
Jan 4, 2008·The Journal of Clinical Investigation·Marta Martinez-VicenteAna Maria Cuervo
Oct 1, 2008·Annals of Neurology·Gregor K WenningMichael G Schlossmacher
Nov 11, 2008·Annals of the New York Academy of Sciences·James P O'CallaghanDiane B Miller
Mar 24, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·David J BrooksUNKNOWN Neuroimaging Working Group on MSA
Nov 18, 2009·Journal of Neuropathology and Experimental Neurology·Yun Ju C SongTamas R Revesz
Dec 17, 2009·Acta Neuropathologica·Michael V Sofroniew, Harry V Vinters
Dec 17, 2009·Acta Neuropathologica·Manuel B Graeber, Wolfgang J Streit
Mar 9, 2010·CNS & Neurological Disorders Drug Targets·Carol A Colton, Donna M Wilcock
May 21, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Evangelia EmmanouilidouKostas Vekrellis
Aug 14, 2010·Current Opinion in Neurobiology·Christopher N Parkhurst, Wen-Biao Gan
Oct 6, 2010·Neuron·Kiran BhaskarBruce T Lamb
Oct 26, 2010·Oxidative Medicine and Cellular Longevity·He-Jin LeeSeung-Jae Lee
Nov 3, 2010·Annual Review of Pathology·Joshua M ShulmanMel B Feany
Feb 16, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Glenda M Halliday, Claire H Stevens

❮ Previous
Next ❯

Citations

Apr 6, 2017·Current Neurology and Neuroscience Reports·Brice LaurensWassilios G Meissner
Apr 22, 2017·Multiple Sclerosis and Related Disorders·Urška LamotKatarina Šurlan Popovič
Oct 7, 2017·Journal of Alzheimer's Disease : JAD·Kurt A Jellinger
Mar 5, 2018·Journal of Cellular and Molecular Medicine·Elena AbatiStefania Corti
May 21, 2018·The European Journal of Neuroscience·Jintang WangSean X Leng
Nov 20, 2018·Movement Disorders : Official Journal of the Movement Disorder Society·Antonio Heras-GarvinNadia Stefanova
Feb 7, 2019·Movement Disorders : Official Journal of the Movement Disorder Society·Dorothee KüblerAlexander Gerhard
Nov 18, 2018·Brain Pathology·Alana HoffmannJürgen Winkler
Apr 22, 2016·Journal of Neural Transmission·Kurt A Jellinger, Gregor K Wenning
Jun 13, 2019·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Alain NdayisabaNadia Stefanova
Jan 30, 2018·Journal of Alzheimer's Disease : JAD·Christine KaindlstorferGregor K Wenning
Jan 26, 2020·Journal of Neuroinflammation·Antonio Heras-GarvinNadia Stefanova
Nov 20, 2019·Experimental & Molecular Medicine·He-Jin LeeSeung-Jae Lee
Jul 28, 2019·The Journal of Experimental Medicine·Veronika KanaMiriam Merad
Oct 8, 2017·Scientific Reports·Takanobu YoshiiKenji Fukui
Apr 22, 2019·Acta Neuropathologica·Javier Alegre-AbarrateguiChristos Proukakis
Jul 14, 2019·Acta Neuropathologica Communications·Giacomo Monzio Compagnoni, Alessio Di Fonzo
Feb 26, 2020·Translational Neurodegeneration·Seiji KajiRyosuke Takahashi
Nov 5, 2019·Frontiers in Neuroscience·Chunchen XiangShuyan Cong
Mar 1, 2017·International Journal of Molecular Sciences·Dario ValdinocciDean L Pountney
Apr 20, 2017·Frontiers in Neuroscience·Yuho OkitaDean L Pountney
Apr 13, 2019·Journal of Neuroinflammation·Alain NdayisabaGregor K Wenning
Oct 18, 2018·Molecular Neurodegeneration·Olivia J ConwayNilüfer Ertekin-Taner
Apr 23, 2020·International Journal of Molecular Sciences·Lisa MészárosJürgen Winkler
Oct 6, 2020·Frontiers in Cell and Developmental Biology·Maria FoukaMaria Xilouri
Dec 24, 2018·International Journal of Molecular Sciences·Dario ValdinocciDean L Pountney
Oct 28, 2020·Movement Disorders : Official Journal of the Movement Disorder Society·Alexey A ShadrinManu Sharma
Oct 17, 2020·Human Brain Mapping·Natalia Del CampoOlivier Rascol
Jun 3, 2021·International Journal of Molecular Sciences·Panagiota Mavroeidi, Maria Xilouri
Aug 17, 2021·Journal of Neural Transmission·Miguel LemosNadia Stefanova

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic

Related Concepts

Related Feeds

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Atypical Parkinsonism (MDS)

Atypical Parkinsonism presents with the same signs and symptoms of Parkinson's disease, but do not respond to typical Parkionson's disease treatment with levodopa. Atypical Parkinsonism is thought to be associated with abnormal protein buildup within brain cells. Here is the latest on Atypical Parkinsonism.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Related Papers

Current Topics in Behavioral Neurosciences
Lisa FellnerNadia Stefanova
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society
Jose-Alberto Palma, Horacio Kaufmann
© 2022 Meta ULC. All rights reserved